
Chemical and Pharmaceutical Bulletin p. 867 - 870 (1998)
Update date:2022-08-05
Topics:
Asagarasu, Akira
Takayanagi, Nao
Achiwa, Kazuo
Some dipeptide-type human immunodeficiency virus (HIV) protease inhibitors derived from KNI-102, with a N-carbomethoxycarbonylprolyl- phenylalanine benzyl ester (CPF) moiety as a binding site to gp120, were synthesized. Compounds 11a showed 7 - 100 times higher HIV protease- inhibitory activity (11a; IC50 = 0.90 μg/ml, 1.1 μM) than the standard compound 3 or 4 (3; IC50 = 3.7 μg/ml, 7.7 μM, 4; IC50 = 75 μg/ml, 155 μM). Generally, the compounds substituted at the o-position of the phenoxyacetyl group 7a, 11a, 16a and 21a showed several times higher inhibitory activity than 3.
View MoreNanjing Zelang Medical Technology Co. Ltd
Contact:86-25-83063290/13770714480
Address:Ganjiabian 108# 01 Unit,701-702 room,Yao Hua Street,Qixia District,Nanjing,Jiangsu,China
Angelisun(Chongqing) Pharmaceutical Co., LTD.
Contact:+86-23-68030926-816
Address:D1-7 Tech & Entrepreneurs Park, Kecheng Road, Erlang Hi-Tech Areas, Chongqing, China
Reliability Assessment Solutions (Changhzou) Co., Ltd.
Contact:86-519-85607515
Address:RM 601-603 BD1 Fuchen Mansion, 8 Taihu East RD, Xinbei District, Changhou, Jiangsu 213022, China
Jiangsu Dacheng Pharmaceutical and Chemical Co.,Ltd
Contact:+86-0517-87036900
Address:Chuzhou Chemical park, Huai'an, Jiangsu Province
Shijiazhuang City Xiehe Pharmaceutical Co., Ltd
Contact:+86-311-80817929
Address:Shangzhuang,Shijiazhuang,China
Doi:10.1016/S0008-6215(97)10082-9
(1998)Doi:10.1021/ol025909w
(2002)Doi:10.1002/ejoc.201301468
(2014)Doi:10.1016/S0040-4039(00)60395-7
(1993)Doi:10.1016/S0960-894X(98)00215-7
(1998)Doi:10.1021/ja9803411
(1998)